ConductScience.org, home

Paper41535889

O-GlcNAcylation of NONO mediates alternative splicing of SETMAR and facilitates NHEJ repair.

Li M and 9 others. Genome Biol, 2026. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. O-GlcNAcylation of NONO mediates alternative splicing of SETMAR and facilitates NHEJ repair. Papers, record 41535889. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41535889

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
O-GlcNAcylation of NONO mediates alternative splicing of SETMAR and facilitates NHEJ repair.
PubMed
Journal
Genome Biol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-06-26
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li MMengyuan
2Tian HHuanna
3Zhou ZZiyi
4Jiang YYuhan
5Guo XXiaomeng
6Qin WWeijie
7Zhang HHongbing
8Jiao YYajie
9Guo SShuai
10Wu CChen

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alternative SplicingMajor topic
DNA End-Joining RepairMajor topic
RNA-Binding ProteinsMajor topic
Histone-Lysine N-MethyltransferaseMajor topic
Humans
DNA Damage
Protein Processing, Post-Translational
Animals
Ubiquitination
Histones
Ku Autoantigen
Cell Line, Tumor
Acetylglucosamine

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
32071277National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References69

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130105004O-GlcNAc: A Sweetheart of the Cell Cycle and DNA Damage Response.Front Endocrinol (Lausanne)2018https://conductscience.org/library/papers/30105004PubMed
232142654Regulation of the RNAPII Pool Is Integral to the DNA Damage Response.Cell2020https://conductscience.org/library/papers/32142654PubMed
331654859Molecular mechanisms regulating O-linked N-acetylglucosamine (O-GlcNAc)-processing enzymes.Curr Opin Chem Biol2019https://conductscience.org/library/papers/31654859PubMed
437834403New Facets of DNA Double Strand Break Repair: Radiation Dose as Key Determinant of HR versus c-NHEJ Engagement.Int J Mol Sci2023https://conductscience.org/library/papers/37834403PubMed
532176524Checkpoint Responses to DNA Double-Strand Breaks.Annu Rev Biochem2020https://conductscience.org/library/papers/32176524PubMed
637595040FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer.Sci Adv2023https://conductscience.org/library/papers/37595040PubMed
727458206OGT restrains the expansion of DNA damage signaling.Nucleic Acids Res2016https://conductscience.org/library/papers/27458206PubMed
820068230Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis.Sci Signal2010https://conductscience.org/library/papers/20068230PubMed
926286029VE-821, an ATR inhibitor, causes radiosensitization in human tumor cells irradiated with high LET radiation.Radiat Oncol2015https://conductscience.org/library/papers/26286029PubMed
1038215753Poly(ADP-ribosyl)ation enhances nucleosome dynamics and organizes DNA damage repair components within biomolecular condensates.Mol Cell2024https://conductscience.org/library/papers/38215753PubMed
1120192759The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.Annu Rev Biochem2010https://conductscience.org/library/papers/20192759PubMed
1238447797OGT and OGA: Sweet guardians of the genome.J Biol Chem2024https://conductscience.org/library/papers/38447797PubMed
1335974014DNA damage-induced paraspeckle formation enhances DNA repair and tumor radioresistance by recruiting ribosomal protein P0.Cell Death Dis2022https://conductscience.org/library/papers/35974014PubMed
1434249431NONO phase separation enhances DNA damage repair by accelerating nuclear EGFR-induced DNA-PK activation.Am J Cancer Res2021https://conductscience.org/library/papers/34249431PubMed
1516964247Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability.Nat Cell Biol2006https://conductscience.org/library/papers/16964247PubMed
1635563044DNA Double-Strand Breaks as Pathogenic Lesions in Neurological Disorders.Int J Mol Sci2022https://conductscience.org/library/papers/35563044PubMed
1735318271DNA repair defects in cancer and therapeutic opportunities.Genes Dev2022https://conductscience.org/library/papers/35318271PubMed
1829084613H2A O-GlcNAcylation at serine 40 functions genomic protection in association with acetylated H2AZ or γH2AX.Epigenetics Chromatin2017https://conductscience.org/library/papers/29084613PubMed
1934339852Decoding Post-Translational Modification Crosstalk With Proteomics.Mol Cell Proteomics2021https://conductscience.org/library/papers/34339852PubMed
2034813349DNA End Resection: Mechanism and Control.Annu Rev Genet2021https://conductscience.org/library/papers/34813349PubMed

See all 69 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42975739Integrative multi-omics analysis reveals a GALNT6/Smad2/CDC7 axis promoting cisplatin resistance through enhanced DNA damage repair in bladder cancer.Funct Integr Genomics2026https://conductscience.org/library/papers/42975739PubMed
42846024NONO modulates tumorigenesis and metastatic potential of lung squamous cell carcinoma.Front Oncol2026https://conductscience.org/library/papers/42846024PubMed
42751272Post-translational modification in hepatocellular carcinoma resistance: molecular mechanisms and therapeutic targeting.Front Immunol2026https://conductscience.org/library/papers/42751272PubMed
42639267RNA-Binding Proteins: Function, Biological Mechanisms, and Therapeutic Opportunities.MedComm (2020)2026https://conductscience.org/library/papers/42639267PubMed
42449693αS-SETMAR: Inducing Protective Chaos in Glioblastoma?Cancers (Basel)2026https://conductscience.org/library/papers/42449693PubMed
42088439CAF-derived exosomal circMPP6 drives ovarian cancer metastasis by coordinating nuclear and cytoplasmic regulation of ADAM22 to activate TGF-β/Smad signaling.Int J Biol Sci2026https://conductscience.org/library/papers/42088439PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
NONO4841PubTator's text mininghttps://conductscience.org/library/genes/4841NCBI Gene
PRDM956979PubTator's text mininghttps://conductscience.org/library/genes/56979NCBI Gene
SETMAR6419PubTator's text mininghttps://conductscience.org/library/genes/6419NCBI Gene
SFPQ6421PubTator's text mininghttps://conductscience.org/library/genes/6421NCBI Gene
XRCC62547PubTator's text mininghttps://conductscience.org/library/genes/2547NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41535889

GET https://conductscience.org/api/papers/v1/41535889/references?page=2